Navigation Links
VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
Date:8/19/2008

- First Product Developed from the VisEn-Merck & Co., Inc. Biomarker Imaging Program -

- Expands VisEn's Leading Fluorescence Molecular Imaging Agent Portfolio and Broadens Applications in Key Areas of Disease Research and Drug Development -

BEDFORD, Mass., Aug. 19 /PRNewswire/ -- VisEn Medical, Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its IntegriSenseTM fluorescence in vivo imaging agent product line. The agent is the first product developed out of the Merck-VisEn Biomarker Imaging research collaboration announced in 2007, and will enable researchers to image and assess the role of integrin alpha v beta 3 in disease progression and therapeutic response in vivo.

IntegriSense is an optimized in vivo fluorescence imaging agent targeting integrin alpha v beta 3, a key biomarker closely associated with disease-related vascularity and angiogenesis. The agent was developed to enable in vivo imaging of integrin alpha v beta 3 expression in order to measure and monitor aspects of disease progression and therapeutic response in disease states including oncology, cardiovascular disease, and bone disease.

"The integrin alpha v beta 3 protein plays an important key role in many disease pathways, which is one of the key reasons we selected this as a first imaging target with our collaborators at Merck," said Kirtland Poss, President and CEO of VisEn Medical. "IntegriSense should enable researchers to drive valuable new insights into disease progression and therapeutic mechanisms of action in vivo. We are pleased to be providing our customers the continually expanding ability to generate such rich information on their disease biologies and pathways of interest."

VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic Imaging Systems (FMT), provide the industry's most robust fluores
'/>"/>

SOURCE VisEn Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
2. VisEn Medical Raises $7 Million in Series B Financing
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Rancho BioSciences , the scientific data ... Suite with tranSMART . Scientists that have ... data in tranSMART to Array Suite for further analysis. ... including the new 1.2 release. Array Suite provides ... the analysis of high dimensional quantification data, including expression, ...
(Date:7/31/2014)... 31, 2014 “Rapid technological advances ... the U.S., increasing unemployment, depressing American consumer spending ... is a Catch 22—we need automated manufacturing if ... fewer jobs,” says economist and corporate relocation expert ... Top 10 Pro-Business States for 2014, co-published with ...
(Date:7/31/2014)... The Kidney Cancer Association (KCA) has established ... magazine, Kidney Cancer News. , Bill Bro, KCA CEO, ... maintained by an international news organization. When we began using ... , This month’s program highlights news of an enzyme that ... a recent study. Kidney Cancer News also presents a report ...
(Date:7/30/2014)... Calif. , July 30, 2014 ... a biopharmaceutical company leading the discovery and development of ... report financial results and highlights for the quarter ended ... the U.S. financial markets close. Regulus ... August 6, 2014, at 5:00 pm Eastern Daylight Time ...
Breaking Biology Technology:Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... 2012 IndustryWeek magazine today named the ... in Austin, Texas, one of its Top Ten Plants in ... to win the prestigious award.  IndustryWeek noted the ... margins since 2007; 94% error reduction in production documentation process; ...
... BLUE BELL, Pa., Jan. 11, 2012  Inovio Pharmaceuticals, Inc. (NYSE Amex: ... diseases, announced today that Dr. J. Joseph Kim, President and CEO, will ... Conference. Noble Financial 8th Annual Equity Conference ... Hard Rock Hotel   Inovio Presentation ...
... VILLUM FOUNDATION paves the way for a brand new professorship ... in the field of quantum physics, Professor Charles Marcus. ... a physicist of international standing the Niels Bohr Institute can ... DKK from the VILLUM FOUNDATION. The grant has allowed for ...
Cached Biology Technology:Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 2Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 3Life Technologies Plant in Austin, Texas Named One of IndustryWeek's Top Ten Best Plants for 2011 4Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference 2Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference 3Niels Bohr Institute gets top researcher from Harvard 2Niels Bohr Institute gets top researcher from Harvard 3
(Date:7/31/2014)... NCT00518336) shows the sustained efficacy, immunogenicity and ... vaccine Cervarix. Women vaccinated with the HPV-16/18 ... nine years, and vaccine efficacy (VE) against ... longest follow-up report for a licensed HPV ... full paper. , HPV and vaccination ...
(Date:7/31/2014)... release is available in German . ... take up gases similar to a sponge that soaks ... for storing hydrogen or greenhouse gases. However, loading of ... Institute of Technology (KIT) now report in Nature ... of the MOF surface. This can be prevented by ...
(Date:7/31/2014)... Becquerel first discovered the photovoltaic effect in 1839, humankind ... of sunlight for its own purposes. In a new ... the FASEB Journal , scientists may ... of sunlight by focusing on a naturally occurring combination ... This conservationor persistence over time and across speciessuggests that ...
Breaking Biology News(10 mins):Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3Free pores for molecule transport 2Scientists shine bright new light on how living things capture energy from the sun 2
... An international research team coordinated at the IRCM in ... Led by Dr. Tarik Mry, the IRCM,s President and ... the disease,s "Achilles, heel" and could be targeted to ... effects of current treatments such as chemotherapy and radiation ...
... behave differently. However, that difference isn,t taken into account ... children from chemical exposure, according to Cheryl Rosenfeld, associate ... Bond Life Sciences Center. A series of experiments by ... A (BPA) on later reproductive-associated behaviors using a socially ...
... Scientists at the University of Southampton have created a new ... bone repair therapies for people with bone fractures or those ... The research, carried out by Dr Emmajayne Kingham at ... Glasgow and published in the journal Small , cultured ...
Cached Biology News:Researchers discover 'Achilles' heel' for lymphoid leukemia 2Bisphenol A affects sex-specific reproductive behaviors in a monogamous animal species 2Stem cell breakthrough could lead to new bone repair therapies on nanoscale surfaces 2
... Platypus Contact Printing Kit contains choice ... with series of 100 / 200 micron ... or 200 um x 10 mm lines, ... 20, 40 or 60 nm and pitch ...
Request Info...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
... are supplied as 10X concentrated solutions. REact Buffer ... of the REact buffers and one 250 microl ... four 1 ml vials of REact 1 Buffer ... four 1 ml vials of REact 3 Buffer ...
Biology Products: